A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Parathyroid Cancer Bookmark and Share

Parathyroid Cancer

City of Hope’s comprehensive approach to parathyroid cancer encompasses sophisticated diagnostic techniques and leading-edge surgical, radiotherapy and chemotherapy treatments for these types of cancers. City of Hope also employs new experimental therapies, which may not be available elsewhere, to fight advanced, aggressive parathyroid cancers.

Parathyroid cancer patients at City of Hope receive treatment from a coordinated, multidisciplinary team of surgeons, oncologists, endocrinologists, radiation oncologists, nurses, supportive care specialists and others, ensuring the highest possible standard of care.
 
About Parathyroid Cancer
 
Parathyroid tumors occur in the parathyroid glands, four small glands located behind the thyroid. Although the majority of parathyroid tumors are benign, carcinomas of the parathyroid (parathyroid cancer) do develop, and it is important to be able to properly diagnose and treat them.

The parathyroid glands secrete a hormone called parathyroid hormone (also known as PTH or parathormone), which regulates the body’s calcium levels. PTH acts on special PTH receptors in three key areas of the body: the bones, kidneys and intestines.

PTH mobilizes the bones to release stored calcium, increases calcium reabsorption from the kidneys, and increases calcium absorption in the intestines via activation of vitamin D. The more PTH secreted, the higher the resulting level of blood calcium. Like many systems in the body, the parathyroids respond to feedback inhibition, so that if blood calcium is very high, this signals the parathyroid glands to reduce PTH production.

When parathyroid tumors develop, they cause heightened production of PTH, which in turn results in elevated blood calcium levels (a condition known as hypercalcemia). The tumor may affect a single gland, or tumors may occur simultaneously in multiple glands. This is more common in certain genetic diseases.

Parathyroid cancer is generally slow-growing and rarely metastases. However, the hyperparathyroidism (excess production of PTH) caused by the parathyroid tumors can be quite dangerous. Additionally, parathyroid tumors have a reasonably high degree of recurrence. Therefore, adept surgical management and supportive care to manage percalcemia is important in effective treatment of parathyroid cancer.
 
 
Parathyroid Cancer Risk Factors
 
  • Age: Most patients are diagnosed in their 40s or 50s.
  • Family history of parathyroid tumors
  • External radiation exposure, especially to the head and neck
  • End-stage renal disease/hemodialysis patients
 
Parathyroid Cancer Symptoms
 
Most parathyroid cancer symptoms are caused by the hypercalcemia that develops. Symptoms of hypercalcemia include the following:
 
  • Weakness
  • Feeling very tired
  • Nausea and vomiting
  • Loss of appetite
  • Being much more thirsty than usual
  • Urinating much more than usual
  • Constipation
 
 
Other symptoms of parathyroid cancer include the following:
 
  • Pain in the abdomen, side or back that doesn't go away
  • Pain in the bones
  • A broken bone
  • A lump in the neck
  • Change in voice such as hoarseness
  • Trouble swallowing
  • Kidney stones
  • Renal insufficiency
  • Peptic ulcer disease
  • Recurrent severe pancreatitis
  • Anemia
 

Parathyroid Cancer Staging

Staging is the process of finding out if and how far a cancer has spread. The stage of a cancer is one of the most important factors in choosing treatment options and predicting your chance for cure and long-term survival.
 
Staging is based on the results of the physical exam, the physician’s impression during or after surgery to remove the tumor (presence or absence of the tumor to the thyroid and other organs) and imaging tests (ultrasound, computed tomography scan, magnetic resonance imaging, chest X-ray and/or radioisotope scans).
 
There is no standard staging process for parathyroid cancer. Parathyroid cancer is described as either localized or metastatic:
 
  • Localized parathyroid cancer is found in a parathyroid gland and may have spread to nearby tissues.
  • Metastatic parathyroid cancer has spread to other parts of the body such as the lungs, liver, bone, pericardium (the sac surrounding the heart), pancreas or lymph nodes.
 

Diagnosing Parathyroid Cancer

Parathyroid cancer is not easy to diagnose. It is often difficult to distinguish between a benign parathyroid tumor and parathyroid cancer. Therefore, a variety of tests may be used to establish a diagnosis.
 
Neck palpation

This simple test, which involves your doctor feeling the area around the front of your neck near the thyroid gland, may reveal a cancerous parathyroid tumor. More than 30 percent of parathyroid cancers present with a palpable neck mass.
 
Blood tests

Parathyroid hormone level
Extremely high levels of parathyroid hormone (PTH) may indicate parathyroid cancer yet benign parathyroid adenomas also cause elevated parathyroid hormone levels. Generally, the levels seen in parathyroid cancer are significantly higher.

Serum calcium level
Increased PTH production from either a benign parathyroid adenoma or a malignant parathyroid carcinoma, results in hypercalcemia, producing substantially elevated serum calcium levels. Patients with serum calcium levels exceeding 14 mg/dL, particularly those with a palpable neck mass, may be more likely to have parathyroid cancer.

Alkaline phosphatase level
In many cancers, increased alkaline phosphatase levels serve as a tumor marker indicating bone metastases. In parathyroid cancer, the mobilization of calcium from the bones to the blood also causes alkaline phosphatase levels to increase. These levels are generally elevated significantly beyond the normal range in parathyroid cancer patients

Renal function tests
Certain indicators of renal function such as levels of blood urea nitrogen and creatinine, are more likely to be abnormal in parathyroid cancer.

Sestamibi Scan
In this test, your doctor injects a solution of the radioactive isotope Technetium-99m-sestamibi (sestamibi is the name of the molecule to which the technetium is attached) intravenously. The technetium emits low-energy gamma rays, which can be counted and turned into an image by a “gamma camera” in a process known as scintigraphy.

The premise of the test is that the radiolabeled sestamibi is absorbed by hyperfunctioning (overactive) parathyroid glands, but not in normal parathyroid glands. Therefore, the malfunctioning gland (whether it is a benign adenoma or a malignant carcinoma) can be precisely identified.

Ultrasound
To further characterize your parathyroid tumor, your doctor may suggest an ultrasound. This simple, quick and painless test passes a wand, called a transducer, which emits sound waves, over the neck area to produce an image. Based on this image, your doctor can determine the size, shape and exact location of the parathyroid tumor.

CT, MRI and PET scans
Computed tomography (CT) and magnetic resonance imaging (MRI) scans are sometimes used to stage parathyroid cancer. Staging means gauging the extent of spread of the cancer. They are also used to check for recurrence of the cancer in the neck and if it has spread to other parts of the body. However, CT or MRI scans are rarely used for a definitive initial diagnosis. Posititron emission tomography (PET) scans use a modified sugar compound called fluorodeoxyglucose (FDG). The scan picks up areas of cells that preferentially absorb the FDG. PET scans are also useful to assess spread throughout the neck and in order to monitor for possible recurrence.

Venous sampling
If imaging tests do not show which parathyroid gland is overactive, blood samples may be taken from veins near each parathyroid gland to find which one is making too much PTH.

Biopsy
Unlike in thyroid cancer, biopsy in parathyroid cancer is typically not recommended. If your doctor suspects parathyroid cancer and intends on doing a biopsy to confirm it, you may wish to seek a second opinion. This is because in doing a parathyroid biopsy, there is a significant risk that the capsule of the parathyroid may rupture, causing microscopic tumor cells to seed, or spread – a disastrous consequence.

Parathyroid Treatment Approaches

Department of Surgery
First-line treatment for parathyroid cancer is surgery. The recommended procedure involves removing the entire parathyroid gland, along with that half of the thyroid gland nearest the tumor (hemithyroidectomy) and nearby lymph nodes. If the recurrent laryngeal nerve is involved, it must also be resected. If the cervical lymph nodes are involved, a more extensive “lateral neck dissection” is then performed.

If the tumor has affected neighboring tissue and cannot be completely removed, then debulking of the tumor (removing as much of the tumor as possible) is performed.

Because parathyroid cancer grows very slowly, cancer that has spread to other parts of the body may be removed by surgery and the disease process may be controlled for a considerable period of time. This is known as metastasectomy.

Surgery for parathyroid cancer sometimes damages nerves of the vocal cords. There are treatments to help with speech problems caused by this nerve damage.

During surgery, the lymph nodes are examined and may be removed if cancerous. In medullary thyroid cancer, in addition to total thyroidectomy, a central neck dissection (removal of all lymph nodes and fatty tissues in the central neck area) is usually performed.

In many cases of well-differentiated, localized thyroid cancer, thyroidectomy affords an excellent chance of cure or long-term survival. However, radioiodine therapy (discussed below) is usually given to destroy any residual thyroid cancer cells that may remain after thyroidectomy. Regular follow-up visits with your physician, which includes diagnostic scans, are important to detect any recurrence.

Radiation Therapy
In general, radiation therapy is rarely used to control tumor growth and reduce hormone production. In some cases, external radiation to the neck in microscopic residual disease has been shown to help in curbing recurrence.

Follow-up
Because parathyroid cancer can recur, parathyroid cancer patients should be followed closely for any signs of recurrence or metastasis. This is accomplished by regular physical exams that include neck palpation, monitoring of blood levels of calcium and parathyroid hormone, as well as sestamibi or thallium scans to detect hyperfunctioning parathyroid tissue. Ultrasound, computed tomography and magnetic resonance imaging may also be useful imaging methodologies.

Supportive Care

To manage patients after surgery who have low calcium levels, the following may be prescribed:
 
  • Calcium supplements
  • Calcitriol

Occasionally, the parathyroid cancer patient continues to have some degree of hypercalcemia, which can be managed with:
 
  • IV fluids
  • Diuretics
  • Drugs that inhibit bone resorption
  • Drugs that inhibit PTH secretion

Clinical Trials
City of Hope has several clinical trials involving experimental therapies for advanced solid tumors of the head and neck. Some of these may apply to parathyroid cancer.  Click here for more information.

Parathyroid Cancer Resources

All of our patients also have access to the Sheri & Les Biller Patient and Family Resource Center, which offers a wide array of support and educational services. Patients and loved ones may work with a coordinated group of social workers, psychiatrists, psychologists, patient navigators, pain management specialists and spiritual care providers at the center, as well as participate in programs such as music therapy, meditation and many others.
 
Additional Resources
EndocrineWeb
EndocrineWeb is a comprehensive Web site for thyroid, parathyroid and other endocrine disorders intended for the education of patients and their families. All pages were written by physicians who treat these diseases.
www.endocrineweb.com
 
Phone: 800-ACS-2345
For TYY: 866-228-4327
The American Cancer Society has many national and local programs, as well as a 24-hour support line, to help cancer survivors with problems such as travel, lodging and emotional issues.
www.cancer.org
 
National Comprehensive Cancer Network (NCCN)
Phone: 888-909- NCCN (6226)
The National Comprehensive Cancer Network is an alliance of 19 of the world's leading cancer centers, is an authoritative source of information to help patients and health professionals make informed decisions about cancer care.
www.nccn.org
 
National Cancer Institute (NCI)
Phone: 800-4-CANCER
The National Cancer Institute, established under the National Cancer Act of 1937, is the federal government's principal agency for cancer research and training.
www.cancer.gov
U.S. Dept. of Health and Human Services National Institutes of Health (NIH)
Phone: 301-496-4000
For TYY: 301-402-9612
The National Institutes of Health (NIH) is one of the world's foremost medical research centers, and the federal focal point for medical research in the United States. The NIH, comprising 27 separate institutes and centers, is one of eight health agencies of the Public Health Service, which, in turn, is part of the U.S. Department of Health and Human Services.
www.nih.gov
 

Parathyroid Cancer Team

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Kimberly Wah
Director
Phone: 213-241-7275
Email: kwah@coh.org

 
 

Parathyroid Cancer

Parathyroid Cancer

City of Hope’s comprehensive approach to parathyroid cancer encompasses sophisticated diagnostic techniques and leading-edge surgical, radiotherapy and chemotherapy treatments for these types of cancers. City of Hope also employs new experimental therapies, which may not be available elsewhere, to fight advanced, aggressive parathyroid cancers.

Parathyroid cancer patients at City of Hope receive treatment from a coordinated, multidisciplinary team of surgeons, oncologists, endocrinologists, radiation oncologists, nurses, supportive care specialists and others, ensuring the highest possible standard of care.
 
About Parathyroid Cancer
 
Parathyroid tumors occur in the parathyroid glands, four small glands located behind the thyroid. Although the majority of parathyroid tumors are benign, carcinomas of the parathyroid (parathyroid cancer) do develop, and it is important to be able to properly diagnose and treat them.

The parathyroid glands secrete a hormone called parathyroid hormone (also known as PTH or parathormone), which regulates the body’s calcium levels. PTH acts on special PTH receptors in three key areas of the body: the bones, kidneys and intestines.

PTH mobilizes the bones to release stored calcium, increases calcium reabsorption from the kidneys, and increases calcium absorption in the intestines via activation of vitamin D. The more PTH secreted, the higher the resulting level of blood calcium. Like many systems in the body, the parathyroids respond to feedback inhibition, so that if blood calcium is very high, this signals the parathyroid glands to reduce PTH production.

When parathyroid tumors develop, they cause heightened production of PTH, which in turn results in elevated blood calcium levels (a condition known as hypercalcemia). The tumor may affect a single gland, or tumors may occur simultaneously in multiple glands. This is more common in certain genetic diseases.

Parathyroid cancer is generally slow-growing and rarely metastases. However, the hyperparathyroidism (excess production of PTH) caused by the parathyroid tumors can be quite dangerous. Additionally, parathyroid tumors have a reasonably high degree of recurrence. Therefore, adept surgical management and supportive care to manage percalcemia is important in effective treatment of parathyroid cancer.
 
 
Parathyroid Cancer Risk Factors
 
  • Age: Most patients are diagnosed in their 40s or 50s.
  • Family history of parathyroid tumors
  • External radiation exposure, especially to the head and neck
  • End-stage renal disease/hemodialysis patients
 
Parathyroid Cancer Symptoms
 
Most parathyroid cancer symptoms are caused by the hypercalcemia that develops. Symptoms of hypercalcemia include the following:
 
  • Weakness
  • Feeling very tired
  • Nausea and vomiting
  • Loss of appetite
  • Being much more thirsty than usual
  • Urinating much more than usual
  • Constipation
 
 
Other symptoms of parathyroid cancer include the following:
 
  • Pain in the abdomen, side or back that doesn't go away
  • Pain in the bones
  • A broken bone
  • A lump in the neck
  • Change in voice such as hoarseness
  • Trouble swallowing
  • Kidney stones
  • Renal insufficiency
  • Peptic ulcer disease
  • Recurrent severe pancreatitis
  • Anemia
 

Staging

Parathyroid Cancer Staging

Staging is the process of finding out if and how far a cancer has spread. The stage of a cancer is one of the most important factors in choosing treatment options and predicting your chance for cure and long-term survival.
 
Staging is based on the results of the physical exam, the physician’s impression during or after surgery to remove the tumor (presence or absence of the tumor to the thyroid and other organs) and imaging tests (ultrasound, computed tomography scan, magnetic resonance imaging, chest X-ray and/or radioisotope scans).
 
There is no standard staging process for parathyroid cancer. Parathyroid cancer is described as either localized or metastatic:
 
  • Localized parathyroid cancer is found in a parathyroid gland and may have spread to nearby tissues.
  • Metastatic parathyroid cancer has spread to other parts of the body such as the lungs, liver, bone, pericardium (the sac surrounding the heart), pancreas or lymph nodes.
 

Diagnosing Parathyroid Cancer

Diagnosing Parathyroid Cancer

Parathyroid cancer is not easy to diagnose. It is often difficult to distinguish between a benign parathyroid tumor and parathyroid cancer. Therefore, a variety of tests may be used to establish a diagnosis.
 
Neck palpation

This simple test, which involves your doctor feeling the area around the front of your neck near the thyroid gland, may reveal a cancerous parathyroid tumor. More than 30 percent of parathyroid cancers present with a palpable neck mass.
 
Blood tests

Parathyroid hormone level
Extremely high levels of parathyroid hormone (PTH) may indicate parathyroid cancer yet benign parathyroid adenomas also cause elevated parathyroid hormone levels. Generally, the levels seen in parathyroid cancer are significantly higher.

Serum calcium level
Increased PTH production from either a benign parathyroid adenoma or a malignant parathyroid carcinoma, results in hypercalcemia, producing substantially elevated serum calcium levels. Patients with serum calcium levels exceeding 14 mg/dL, particularly those with a palpable neck mass, may be more likely to have parathyroid cancer.

Alkaline phosphatase level
In many cancers, increased alkaline phosphatase levels serve as a tumor marker indicating bone metastases. In parathyroid cancer, the mobilization of calcium from the bones to the blood also causes alkaline phosphatase levels to increase. These levels are generally elevated significantly beyond the normal range in parathyroid cancer patients

Renal function tests
Certain indicators of renal function such as levels of blood urea nitrogen and creatinine, are more likely to be abnormal in parathyroid cancer.

Sestamibi Scan
In this test, your doctor injects a solution of the radioactive isotope Technetium-99m-sestamibi (sestamibi is the name of the molecule to which the technetium is attached) intravenously. The technetium emits low-energy gamma rays, which can be counted and turned into an image by a “gamma camera” in a process known as scintigraphy.

The premise of the test is that the radiolabeled sestamibi is absorbed by hyperfunctioning (overactive) parathyroid glands, but not in normal parathyroid glands. Therefore, the malfunctioning gland (whether it is a benign adenoma or a malignant carcinoma) can be precisely identified.

Ultrasound
To further characterize your parathyroid tumor, your doctor may suggest an ultrasound. This simple, quick and painless test passes a wand, called a transducer, which emits sound waves, over the neck area to produce an image. Based on this image, your doctor can determine the size, shape and exact location of the parathyroid tumor.

CT, MRI and PET scans
Computed tomography (CT) and magnetic resonance imaging (MRI) scans are sometimes used to stage parathyroid cancer. Staging means gauging the extent of spread of the cancer. They are also used to check for recurrence of the cancer in the neck and if it has spread to other parts of the body. However, CT or MRI scans are rarely used for a definitive initial diagnosis. Posititron emission tomography (PET) scans use a modified sugar compound called fluorodeoxyglucose (FDG). The scan picks up areas of cells that preferentially absorb the FDG. PET scans are also useful to assess spread throughout the neck and in order to monitor for possible recurrence.

Venous sampling
If imaging tests do not show which parathyroid gland is overactive, blood samples may be taken from veins near each parathyroid gland to find which one is making too much PTH.

Biopsy
Unlike in thyroid cancer, biopsy in parathyroid cancer is typically not recommended. If your doctor suspects parathyroid cancer and intends on doing a biopsy to confirm it, you may wish to seek a second opinion. This is because in doing a parathyroid biopsy, there is a significant risk that the capsule of the parathyroid may rupture, causing microscopic tumor cells to seed, or spread – a disastrous consequence.

Parathyroid Treatment Options

Parathyroid Treatment Approaches

Department of Surgery
First-line treatment for parathyroid cancer is surgery. The recommended procedure involves removing the entire parathyroid gland, along with that half of the thyroid gland nearest the tumor (hemithyroidectomy) and nearby lymph nodes. If the recurrent laryngeal nerve is involved, it must also be resected. If the cervical lymph nodes are involved, a more extensive “lateral neck dissection” is then performed.

If the tumor has affected neighboring tissue and cannot be completely removed, then debulking of the tumor (removing as much of the tumor as possible) is performed.

Because parathyroid cancer grows very slowly, cancer that has spread to other parts of the body may be removed by surgery and the disease process may be controlled for a considerable period of time. This is known as metastasectomy.

Surgery for parathyroid cancer sometimes damages nerves of the vocal cords. There are treatments to help with speech problems caused by this nerve damage.

During surgery, the lymph nodes are examined and may be removed if cancerous. In medullary thyroid cancer, in addition to total thyroidectomy, a central neck dissection (removal of all lymph nodes and fatty tissues in the central neck area) is usually performed.

In many cases of well-differentiated, localized thyroid cancer, thyroidectomy affords an excellent chance of cure or long-term survival. However, radioiodine therapy (discussed below) is usually given to destroy any residual thyroid cancer cells that may remain after thyroidectomy. Regular follow-up visits with your physician, which includes diagnostic scans, are important to detect any recurrence.

Radiation Therapy
In general, radiation therapy is rarely used to control tumor growth and reduce hormone production. In some cases, external radiation to the neck in microscopic residual disease has been shown to help in curbing recurrence.

Follow-up
Because parathyroid cancer can recur, parathyroid cancer patients should be followed closely for any signs of recurrence or metastasis. This is accomplished by regular physical exams that include neck palpation, monitoring of blood levels of calcium and parathyroid hormone, as well as sestamibi or thallium scans to detect hyperfunctioning parathyroid tissue. Ultrasound, computed tomography and magnetic resonance imaging may also be useful imaging methodologies.

Supportive Care

To manage patients after surgery who have low calcium levels, the following may be prescribed:
 
  • Calcium supplements
  • Calcitriol

Occasionally, the parathyroid cancer patient continues to have some degree of hypercalcemia, which can be managed with:
 
  • IV fluids
  • Diuretics
  • Drugs that inhibit bone resorption
  • Drugs that inhibit PTH secretion

Clinical Trials
City of Hope has several clinical trials involving experimental therapies for advanced solid tumors of the head and neck. Some of these may apply to parathyroid cancer.  Click here for more information.

Resources

Parathyroid Cancer Resources

All of our patients also have access to the Sheri & Les Biller Patient and Family Resource Center, which offers a wide array of support and educational services. Patients and loved ones may work with a coordinated group of social workers, psychiatrists, psychologists, patient navigators, pain management specialists and spiritual care providers at the center, as well as participate in programs such as music therapy, meditation and many others.
 
Additional Resources
EndocrineWeb
EndocrineWeb is a comprehensive Web site for thyroid, parathyroid and other endocrine disorders intended for the education of patients and their families. All pages were written by physicians who treat these diseases.
www.endocrineweb.com
 
Phone: 800-ACS-2345
For TYY: 866-228-4327
The American Cancer Society has many national and local programs, as well as a 24-hour support line, to help cancer survivors with problems such as travel, lodging and emotional issues.
www.cancer.org
 
National Comprehensive Cancer Network (NCCN)
Phone: 888-909- NCCN (6226)
The National Comprehensive Cancer Network is an alliance of 19 of the world's leading cancer centers, is an authoritative source of information to help patients and health professionals make informed decisions about cancer care.
www.nccn.org
 
National Cancer Institute (NCI)
Phone: 800-4-CANCER
The National Cancer Institute, established under the National Cancer Act of 1937, is the federal government's principal agency for cancer research and training.
www.cancer.gov
U.S. Dept. of Health and Human Services National Institutes of Health (NIH)
Phone: 301-496-4000
For TYY: 301-402-9612
The National Institutes of Health (NIH) is one of the world's foremost medical research centers, and the federal focal point for medical research in the United States. The NIH, comprising 27 separate institutes and centers, is one of eight health agencies of the Public Health Service, which, in turn, is part of the U.S. Department of Health and Human Services.
www.nih.gov
 

Parathyroid Cancer Team

Parathyroid Cancer Team

Support This Program

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Kimberly Wah
Director
Phone: 213-241-7275
Email: kwah@coh.org

 
 
Patient Care Overview

City of Hope Locations

Cancer Care
For the 11th year, U.S.News & World Report has named City of Hope one of the top cancer hospitals in the country.
NEWS & UPDATES
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...
  • Cancer treatment can take a toll on the mouth, even if a patient’s cancer has nothing to do with the head or throat, leading to a dry mouth, or a very sore mouth, and making it difficult to swallow or eat. Here’s some advice from the National Cancer Institute (NCI)  on how to ease cancer-related dis...